contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


inside-information-modulight-has-received-purchase-orders-worth-of-08-million-dollars

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består primärt av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom US.

Här är några nyare nyheter om företaget: Modulight har ingått nya avtal som kommer att ge företaget minst 1,5 miljoner euro i ytterligare intäkter under de kommande två åren. Avtalen omfattar cirka 20 verksamhetsställen, och kunderna inkluderar läkemedelsbolag, sjukhus och kliniker inom cancer- och ögonläkemedel. Modulights modell för behandling-baserad fakturering (PPT) är central och intäkterna från modellen ökar. Företaget uppskattar att avtalen kommer att generera cirka 200 000 euro i intäkter per kvartal, vilket stöder företagets prognoser för stark tillväxt. Modulight förväntar sig att omsättningen ökar från 3,9 miljoner euro (2024) till över 10 miljoner euro år 2026. De nya avtalen stärker tillväxtutsikterna, men större intäkter beror på att projekten övergår till kommersiell fas.

Här är en ny högkvalitativ och bra analys av Modulight.  Modulight’s Q3 report showed no clear signs of a return to growth and revenue landed below expectations. Earnings and cash flow were roughly in line with our forecasts due to lower-than-expected costs. We are lowering our growth and cost forecasts for the coming years, while the business turnaround is still to come. We reiterate our Reduce recommendation and target price of EUR 0.9.                   Inderes              Modulight Q3'24: No clear signs of growth yet - Inderes    Modulight's Q3 report showed no clear signs of a return to growth and revenue landed below expectations. Earnings and cash flow were roughly in line with our forecasts due to lower-than-expected costs.

Modulights Q3-resultat var lägre än förväntat när det gäller omsättningen, även om vinsten och kassaflödet var i linje med prognoserna. Omsättningen påverkades negativt av övergången till PPT-modellen och förseningar i prototypleveranser. Utsikterna för 2024 verkar vara under målen, och rapporten visade ännu inga tecken på tillväxt.                   Inderes              Modulight Q3'24 flash comment: Revenue missed expectations - profit and cash...    Modulight's revenue was well below our expectations, but profit and cash flow were close to our forecasts. Revenue was negatively impacted by the transition to the PPT (pay-per-treatment) model and delays in prototype deliveries.

Modulights Q3-resultat under förväntningarna – intäkterna påverkades av förändringar i intäktsmodellen och leveransförseningar Modulight offentliggjorde på fredagen sitt resultat för tredje kvartalet, där intäkterna var klart lägre än förväntat. Bolagets vinst och kassaflöde motsvarade däremot prognoserna. Intäkterna påverkades negativt av övergången till PPT (pay-per-treatment)-modellen samt förseningar i prototypleveranser. Bolagets utsikter för 2024 ser ut att bli sämre än både bolagets egna och marknadens mål. En webcast hålls på måndag kl. 14.30 EEST för en närmare analys av resultatet, och vi uppdaterar våra bedömningar senast på tisdag. Hittills har rapporten inte visat några tydliga tecken på en återgång till tillväxt.                   Inderes              Modulight Q3'24 flash comment: Revenue missed expectations - profit and cash...    Modulight's revenue was well below our expectations, but profit and cash flow were close to our forecasts. Revenue was negatively impacted by the transition to the PPT (pay-per-treatment) model and delays in prototype deliveries.

Here is a high-quality and free analysis of Modylight.                    Inderes              Modulight: 2023 landed below targets - Inderes    Modulight said its revenue for 2023 will be around 4 MEUR and its EBIT will deteriorate year-on-year. The guidance marks the third consecutive year of business contraction and a clear shortfall against the company's own targets.                             Modulight said its revenue for 2023 will be around 4 MEUR and its EBIT will deteriorate year-on-year. The guidance marks the third consecutive year of business contraction and a clear shortfall against the company’s own targets. We are revising our forecasts for the coming years moderately downwards with the visibility being very low. With the forecast cuts, the stock still looks expensive both in absolute terms and relative to peers. In the coming year, new commercializations can give greater visibility to the company’s future.

Modulight står inför en stenig väg. Trots att marknaden är defensiv och inriktad på framtiden, har den projektbaserade modellen visat sig vara opålitlig, och dess långsiktiga funktionalitet kräver fortfarande bevis. Att förutse omsättning och lönsamhet är som att spela tärning, och synligheten i projekten är alarmerande svag. Kundbasens omognad och koncentration lägger ytterligare tryck, vilket ökar risknivån ytterligare. För Modulight väntar uppenbarligen stormiga vatten. Eller finns det något speciellt med det här företaget som har fått dig eller någon annan att bli intresserad? Tack för svaret redan på förhand!  Jag är mycket dåligt bekant med det här företaget.

Here is a really good analysis.  “The Q2 report was disappointing compared to our expectations and the market reaction was also strongly negative. The company’s revenue of EUR 1.1 million was modest, especially when considering the large contract that still supported the figures in this quarter. We are lowering our estimates for the short and long term in view of the difficulties in the business and the continuing very low visibility. Despite the fall in the share price, the valuation seems even more challenging than before, as in addition to our estimates, our view on the acceptable multiples for the stock has gone down.”                   Inderes — Connecting Investors and Companies              Modulight: Growth not picking up yet    The Q2 report was disappointing compared to our expectations and the market reaction was also strongly negative. The company's revenue of EUR 1.1 million was modest, especially when considering the large contract that still supported the figures in...

Modulight

Modulight Corporation | Company Release | February 25, 2025 at 10:35:00 EETModulight Corporation has received today purchase orders for prototypes to be used in a highly scalable, fault tolerant...

<div class="mfn-header mfn-header-finland"><p>Modulight Corporation | Company Release | February 25, 2025 at 10:35:00 EET</p></div><div class="mfn-body"><p>Modulight Corporation has received today purchase orders for prototypes to be used in a highly scalable, fault tolerant, general purpose quantum computer. Total value of orders from single customer about 0.8 million dollars and is part of earlier started important collaboration. The order is expected to be delivered during the calendar year 2025.</p><p>The customer is a world leading quantum computing company from United States with significant operations globally.&nbsp;Modulights unique technology is used at the core of the Company’s quantum computer technology and Modulight is not providing this technology to any other customer.&nbsp;</p></div><div class="mfn-footer mfn-759371711cfa"><p><strong class="mfn-heading-1">For further information, please contact:</strong></p><hr><p>CEO Seppo Orsila, m. +358 40 830 4671<br><br>IR Ulla Haapanen, m. +358 40 830 4676<br>Email: <a rel="noopener" href="mailto:ir@modulight.com">ir@modulight.com</a></p><p>Certified adviser: Sisu Partners Oy, m. +358 40&nbsp;555 4727<br>&nbsp;<br><a rel="noopener" href="https://modulight.com">modulight.com</a><br><a rel="noopener" href="https://twitter.com/modulight">@modulight</a></p></div><div class="mfn-footer mfn-about mfn-f80935501c1c"><p><strong class="mfn-heading-1">Modulight in brief</strong></p><hr><p>Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.</p><p>Follow&nbsp;Modulight: <a rel="noopener" href="https://modulight.com">modulight.com</a> | <a rel="noopener" href="https://twitter.com/modulight">X&nbsp;</a>|&nbsp;<a rel="noopener" href="https://www.linkedin.com/company/modulight/">LinkedIn</a> | <a rel="noopener" href="https://www.facebook.com/modulight.inc">Facebook</a>&nbsp;|&nbsp;<a rel="noopener" href="https://www.youtube.com/Modulight">YouTube</a>&nbsp;|&nbsp;<a rel="noopener" href="https://www.instagram.com/modulight.inc/">Instagram</a>&nbsp;| #killcancer #laserfamily</p></div>

Inside Information: Modulight has received purchase orders worth of 0.8 million dollars

Sekretessinställningar